One of the largest private health insurers in the U.S. has gone from considering hybrid PET/CT for cardiac indications “experimental/investigational” to displaying willingness to pay for the modality. 

The protocol does not come at the expense of deteriorated image quality, according to work published recently in the European Journal of Radiology.

There is a need to gain a more thorough understanding of how menopause might affect the vascular health of the brain, experts explained in Neurology.

This week Bayer announced the launch of Calantic Digital Solutions, a suite of applications intended to optimize clinical workflows by triaging and prioritizing critical findings, improving disease detection and automating tasks for radiologists. 

Such assessments could “decrease existing diagnosis gaps,” according to a new study published in Academic Radiology. 

This is a trend that researchers believe will persist as disease management continues to improve. 

Researchers recently revamped the database in the hopes of expanding algorithm development in the field of stroke care. 

"Clinical study protocols may involve more than one PET [amyloid-beta] scan per patient,” the CMS announcement said.

These abstracts can be submitted to RSNA starting on July 6, 2022. Submissions will be accepted until August 3 at noon CST. 

PET/CT imaging in these patients increases overall survival depending on the cancer’s stage, with those diagnosed with stage 3A and 3B NSCLC appearing to benefit the most from the exam.